BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23171532)

  • 1. Effect of vascular comorbidities on survival of type 2 diabetes patients on renal replacement therapy.
    Kervinen M; Lehto S; Grönhagen-Riska C; Finne P
    Am J Nephrol; 2012; 36(6):509-15. PubMed ID: 23171532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival of type 2 diabetic patients on renal replacement therapy in Finland.
    Kervinen M; Lehto S; Ikäheimo R; Karhapää P; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2010 Mar; 25(3):892-6. PubMed ID: 19846391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study.
    Liu T; Liang KV; Rosenbaum A; Stephenson R; Pike F; Weissfeld L; Unruh ML
    Nephrol Dial Transplant; 2012 Jul; 27(7):2929-36. PubMed ID: 22273665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.
    Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy.
    van Manen JG; van Dijk PC; Stel VS; Dekker FW; Clèries M; Conte F; Feest T; Kramar R; Leivestad T; Briggs JD; Stengel B; Jager KJ
    Nephrol Dial Transplant; 2007 Jan; 22(1):187-95. PubMed ID: 16998216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy.
    Haapio M; Helve J; Kurimo P; Forslund T; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2012 Mar; 27(3):1157-63. PubMed ID: 21810761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies].
    Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F
    An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study.
    Haynes R; Kheradmand F; Winearls CG
    Nephron Clin Pract; 2012; 120(1):c42-7. PubMed ID: 22205054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peripheral vascular disease on kidney allograft outcomes: a study of U.S. Renal data system.
    Brar A; Jindal RM; Elster EA; Tedla F; John D; Sumrani N; Salifu MO
    Transplantation; 2013 Mar; 95(6):810-5. PubMed ID: 23354295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMI and its association with death and the initiation of renal replacement therapy (RRT) in a cohort of patients with chronic kidney disease (CKD).
    Wang Z; Zhang J; Chan S; Cameron A; Healy HG; Venuthurupalli SK; Tan KS; Hoy WE
    BMC Nephrol; 2019 Aug; 20(1):329. PubMed ID: 31438869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders.
    Karamé A; Labeeuw M; Trolliet P; Caillette-Beaudoin A; Cahen R; Ecochard R; Galland R; Hallonet P; Pouteil-Noble C; Villar E
    Nephron Clin Pract; 2009; 112(4):c268-75. PubMed ID: 19546587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia is common and predicts mortality in diabetic nephropathy.
    Joss N; Patel R; Paterson K; Simpson K; Perry C; Stirling C
    QJM; 2007 Oct; 100(10):641-7. PubMed ID: 17921197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity and mortality in advanced chronic renal failure patients].
    Caravaca F; Martín MV; Barroso S; Arrobas M; Ruiz-Calero R; García MC; Luna E; Sánchez-Casado E
    Nefrologia; 2004; 24(5):453-62. PubMed ID: 15648903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe.
    van de Luijtgaarden MW; Noordzij M; Stel VS; Ravani P; Jarraya F; Collart F; Schön S; Leivestad T; Puttinger H; Wanner C; Jager KJ
    Nephrol Dial Transplant; 2011 Sep; 26(9):2940-7. PubMed ID: 21325351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.